The U.S. Food and Drug Administration on Tuesday approved the first nasal spray that will help with treating major depressive ...
Hosted on MSN13m
FDA Clears Spravato For Monotherapy Depression TreatmentsThe FDA granted approval to Spravato (esketamine) as the first monotherapy for adults with treatment-resistant depression, ...
The original approval required that patients on Spravato also receive an oral antidepressant. Now, the FDA says the drug can ...
The Biden administration's eleventh-hour proposal to lower nicotine concentrations in cigarettes has led some Floridians to ...
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...
The FDA says vaping companies are improperly gaming the court system, filing claims in an appeals court they think will be sympathetic to them.
On his first day in office, President Donald Trump announced plans to pull America from the Paris Agreement and expand the production of oil, both campaign promises.
In a press release issued on Jan 15., the San Antonio-based research team said mutation was more possible in humans.
Judge Matthew Kacsmaryk, a Trump appointee, allowed three states to go forward with a lawsuit that seeks to change how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback